Jcbr. Freitas et al., EFFECT OF BETA-MYRCENE ON PENTOBARBITAL SLEEPING TIME, Brazilian journal of medical and biological research, 26(5), 1993, pp. 519-523
Evidence that beta-myrcene (MYR) interferes with the metabolic activat
ion of premutagens has been provided by in vitro studies. In order to
determine whether MYR also interferes with the in vivo metabolism of x
enobiotics, thereby modifying pharmacological responses to drugs, we i
nvestigated the effects of this monoterpene on pentobarbital (PT) slee
ping time in rats. Two experiments were carried out. In the first, a s
ingle dose of MYR (0.25, 0.5 or 1.0 g/kg po) was given 1 h before PT (
40 mg/kg ip). No effect was observed with the two lowest doses, but th
e highest MYR dose given 1 h before PT increased the PT-induced sleepi
ng time (131 +/- 15 min vs 64 +/- 15 min for controls, mean +/- SD). I
n the second experiment, male rats were treated with MYR (1.0 g/kg po
once a day) for 14 days and injected with PT (40 mg/kg ip) 24 h after
the last dose of MYR. Repeated treatment with MYR markedly reduced PT
sleeping time compared to the vehicle-treated control group (21 +/- 13
min vs 35 +/- 19 min for controls, mean +/- SD). These results indica
te that MYR interferes with the in vivo barbiturate metabolism and sup
port the view that MYR induces the phenobarbital-inducible cytochrome
P-450 (P-450 2B subfamily) enzymes in the rat.